Bahrain vs Eritrea: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Eritrea
100.0%
in 2024
Bahrain rank
1st
Eritrea rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Eritrea
How they compare
Bahrain currently reports 100.0% against 100.0% in Eritrea, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2016 it was Eritrea ahead.
Bahrain ranks 1st and Eritrea ranks 1st of 144 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 63.5% | 96.0% | 32.5% | Eritrea |
| 2020s | 57.5% | 97.8% | 40.2% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Eritrea?
- Bahrain, at 100.0% against 100.0% in Eritrea as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Eritrea?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Eritrea?
- 8 years are reported by both, from 2016 to 2023.
- How do Bahrain and Eritrea rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Eritrea ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.